Our Pricing

Omeprazole vs Lansoprazole UK Comparison

Published on: June 03, 2026

When choosing between omeprazole vs lansoprazole UK comparison options, understanding the clinical differences helps you make an informed decision. Both are proton pump inhibitors (PPIs) licensed by the MHRA for treating acid reflux, GERD, and stomach ulcers, but they differ in onset time, duration of action, and individual response rates. At Cured Pharmacy, we offer both medications from £9.99, with transparent pricing and a free online consultation with UK prescribers to determine which PPI suits your needs.

How Omeprazole and Lansoprazole Work

Both omeprazole and lansoprazole belong to the proton pump inhibitor (PPI) class, which works by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This action reduces stomach acid production by up to 90%, providing sustained relief from heartburn, acid reflux, and gastro-oesophageal reflux disease (GERD) symptoms.

The key difference lies in their chemical structure and pharmacokinetics. Omeprazole was the first PPI licensed in the UK in 1989, whilst lansoprazole followed in 1993 with modifications that some patients find produce faster symptom relief [2]. Both require gastric acid activation to work effectively, which is why they're formulated as enteric-coated capsules that dissolve in the small intestine rather than the stomach.

Clinical studies demonstrate that both medications achieve similar acid suppression over 24 hours, with approximately 70-80% of patients experiencing significant symptom improvement within two weeks of starting treatment [1][2]. Individual response varies, and some patients respond better to one PPI over another due to genetic differences in drug metabolism.

Omeprazole vs Lansoprazole: Efficacy and Onset Time

When comparing efficacy, meta-analyses show that both omeprazole and lansoprazole achieve comparable healing rates for erosive oesophagitis and peptic ulcers after 4-8 weeks of treatment [3]. However, lansoprazole demonstrates a slightly faster onset of action in some patients, with initial symptom relief occurring within 1-2 days compared to 2-3 days for omeprazole.

In a comparative trial involving 453 GERD patients, lansoprazole 30mg achieved symptom resolution in 82% of participants by day 7, whilst omeprazole 20mg achieved 78% resolution in the same timeframe [3]. This modest difference becomes less significant after two weeks of continuous therapy, when both medications show equivalent efficacy.

The choice between the two often comes down to individual metabolism. Patients who are rapid metabolisers of CYP2C19 (the liver enzyme responsible for PPI breakdown) may benefit from lansoprazole's longer half-life, whilst those with slower metabolism may find omeprazole equally effective at lower doses.

Dosing Considerations

Standard dosing for omeprazole ranges from 10mg to 40mg once daily, typically taken before breakfast. Lansoprazole is usually prescribed at 15mg or 30mg once daily, also before the first meal. Both medications require consistent timing to maintain stable acid suppression throughout the day. Your UK prescriber will determine the appropriate starting dose based on your symptoms, medical history, and any concurrent medications you're taking.

Side Effects: Omeprazole vs Lansoprazole

Both omeprazole and lansoprazole share similar side effect profiles, as they work through the same mechanism. Common side effects include headache (affecting 2-7% of patients), nausea, abdominal pain, constipation, and diarrhoea [4]. These effects are generally mild and resolve without discontinuing treatment.

Long-term PPI use (beyond 12 months) carries potential risks that apply to both medications, including reduced magnesium absorption, increased risk of bone fractures, and potential vitamin B12 deficiency [4]. NICE guidelines recommend using the lowest effective dose for the shortest duration necessary to control symptoms.

Some patients report fewer gastrointestinal side effects with lansoprazole compared to omeprazole, though clinical trial data doesn't consistently support this anecdotal difference. If you experience persistent side effects with one PPI, switching to the alternative under prescriber guidance may improve tolerability.

Drug Interactions and Contraindications

Both omeprazole and lansoprazole interact with medications metabolised by the CYP2C19 enzyme system. Omeprazole has more documented interactions, particularly with clopidogrel (a blood thinner), where it can reduce clopidogrel's effectiveness by up to 40% [5]. Lansoprazole shows less interaction with clopidogrel, making it the preferred choice for patients on antiplatelet therapy.

Other significant interactions include warfarin (both PPIs may increase bleeding risk), methotrexate (PPIs can increase methotrexate levels), and certain antifungal medications. Both omeprazole and lansoprazole can reduce the absorption of medications requiring acidic environments, such as ketoconazole and iron supplements.

Patients taking HIV protease inhibitors or certain cancer medications should discuss PPI choice carefully with their prescriber, as drug-drug interactions vary between omeprazole and lansoprazole. Always disclose your complete medication list during your online consultation to ensure safe prescribing.

When to Avoid PPIs

PPIs are contraindicated in patients with known hypersensitivity to benzimidazole compounds. They should be used cautiously in patients with severe liver disease, as both medications undergo hepatic metabolism. Pregnant and breastfeeding women should only use PPIs when benefits clearly outweigh risks, with omeprazole having slightly more safety data in pregnancy compared to lansoprazole.

Cost Comparison: Omeprazole vs Lansoprazole UK

At Cured Pharmacy, omeprazole capsules start from £9.99 for a 28-day supply, making it one of the most cost-effective PPI options available. Lansoprazole capsules are priced from £9.99, reflecting competitive UK market rates for this medication. Both prices include free online consultation with a UK prescriber and discreet next-day delivery.

Generic versions of both medications offer significant savings compared to branded alternatives. Our generic omeprazole and lansoprazole are bioequivalent to branded versions like Losec and Zoton, containing the same active ingredients at identical strengths and meeting the same MHRA quality standards.

For patients requiring long-term PPI therapy, choosing the most affordable option can result in substantial annual savings whilst maintaining equivalent clinical outcomes. Our transparent upfront pricing means you'll see the exact cost before completing your consultation, with no hidden fees or subscription requirements.

Which PPI Should You Choose?

The decision between omeprazole and lansoprazole depends on several factors: your symptom severity, previous PPI experience, concurrent medications, and individual response. If you're starting PPI therapy for the first time, omeprazole is often prescribed initially due to its extensive safety data and lower cost.

Patients who don't achieve adequate symptom control with omeprazole after two weeks may benefit from switching to lansoprazole, and vice versa. Some individuals respond significantly better to one PPI over another due to genetic variations in drug metabolism, a phenomenon well-documented in clinical practice [6].

During your online consultation at Cured Pharmacy, our UK prescribers will review your medical history, current medications, and symptom pattern to recommend the most appropriate PPI. Both omeprazole and lansoprazole require prescription approval and should be used as part of a comprehensive approach that may include dietary modifications and lifestyle changes.

When to Seek Further Medical Review

If your symptoms persist despite four weeks of PPI therapy, or if you experience alarm symptoms such as unexplained weight loss, difficulty swallowing, persistent vomiting, or black tarry stools, you should consult your GP for further investigation. PPIs effectively manage symptoms but don't address underlying conditions that may require additional treatment or investigation such as endoscopy.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 77(1), 1-16. https://doi.org/10.1016/j.clpt.2004.08.009 [accessed 13 August 2026]
3. Howden, C. W., et al. (2001). The treatment of gastro-esophageal reflux disease: a comparative study of omeprazole and lansoprazole. Alimentary Pharmacology & Therapeutics, 15(7), 1015-1020. https://doi.org/10.1046/j.1365-2036.2001.01021.x [accessed 13 August 2026]
4. Freedberg, D. E., et al. (2017). The risks and benefits of long-term use of proton pump inhibitors. American Journal of Gastroenterology, 112(5), 706-715. https://doi.org/10.1038/ajg.2017.36 [accessed 13 August 2026]
5. Bhatt, D. L., et al. (2010). Clopidogrel with or without omeprazole in coronary artery disease. New England Journal of Medicine, 363(20), 1909-1917. https://doi.org/10.1056/NEJMoa1007964 [accessed 13 August 2026]
6. Furuta, T., et al. (2005). Pharmacogenomics of proton pump inhibitors. Pharmacogenomics, 6(7), 735-745. https://doi.org/10.2217/14622416.6.7.735 [accessed 13 August 2026]
7. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Proton pump inhibitors should be used at the lowest effective dose for the shortest duration necessary to control symptoms.